| My Account | Subscribe | Contact Us | Help |
Even drops in the bucket make a difference
It has been 22 years since Air Canada pilot Steve Steele was grounded with type 1
A traveling couple tries to stick to low carbs
Here’s something to make you sit up and take notice (maybe 100 times a night): 23 percent of type 2s have obstructive sleep apnea.
The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!

Related Medications Threads on Diabetes Health Forums
PR Newswire
July 21, 1980, Monday
To Financial; Copy To Medical/Science Editor
INDIANAPOLIS, July 21
Eli Lilly and company today announced that it has begun limited testing in healthy human volunteers of biosynthetic human insulin produced by recombinant DNA technology. The company also announced that it has started construction of the world’s first manufacturing facilities—at a cost of $40 million—to employ recombinant DNA technology to produce the biosynthetic human insulin.
0 comments - Jan 1, 2008 -
Insulin: A Voice for Choice
In the early 1980s, human insulin produced by recombinant DNA technology came onto the market. It was the first time that this technology had been used in medicine, so hopes were high.
7 comments - Nov 23, 2007 -
A high school Spanish teacher in California, Linda Vernier relies on beef-pork insulin from Eli Lilly and Co. to stay healthy.
0 comments - Dec 1, 1999 -
Personal Importation of Animal Insulin
0 comments - Aug 1, 1999 -
Not Yet Rated
Beef-pork insulin will soon disappear in the United States, leaving thousands of people with diabetes without the insulin they feel is essential to their lives. Ever since insulin manufacturers Eli Lilly and Novo Nordisk announced that they would no longer sell beef-pork insulin, American activists have been fighting to import it from the United Kingdom and Brazil, where it is still made and widely available. The activists work on behalf of those who say that human insulin causes side effects in them, the most frequently reported being that they no longer get any physical warning when their blood sugars drop.
0 comments - Aug 1, 1999 -
Not Yet Rated
Christine Klemp of West Bend, Wisconsin, received a shock when she opened her box of insulin on August 16. A message printed in red ink said, "This insulin will be discontinued. Contact your physician to change to another insulin." Klemp was horrified, because this particular insulin (Iletin I beef-pork) is the only insulin that works well for her. "My life is about to come to an end. I just could not believe this was happening."
0 comments - Oct 1, 1998 -
Health Care Professional Calls to Save Insulin
0 comments - Dec 1, 1997 -
Not Yet Rated
0 comments - Oct 1, 1997 -
Not Yet Rated
When human insulin first appeared on the market it was thought to be a "special" insulin and the beef/pork insulin that I had taken for years was termed "standard" insulin. A lot has changed since those days. What was once thought to be the standard is now in danger of being pulled from the market.
0 comments - Oct 1, 1997 -
Not Yet Rated
The British Diabetic Association's (BDA's) insulin campaign is committed to securing choice for people with diabetes for the kind of insulin that they use. The BDA is therefore committed to securing long-term availability of animal and human insulins, and provision of animal insulins in pen cartridges.
0 comments - Oct 1, 1997 -
Not Yet Rated